Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("LOOS M")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 162

  • Page / 7

Export

Selection :

  • and

SATAN ALS ERSTGEBORENER GOTTES. (EIN BEITRAG ZUR ANALYSE DES BOGOMILISCHEN MYTHUS)LOOS M.BYZANT. BULG. 1969, Vol 3, PP. 23-35Article

BIOSYNTHESIS OF THE COLLAGEN LIKE C1Q MOLECULE AND ITS RECEPTOR FUNCTIONS FOR FC AND POLYANIONIC MOLECULES ON MACROPHAGESLOOS M.1983; CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY; ISSN 0070-217X; DEU; DA. 1983; VOL. 102; PP. 1-56; BIBL. 11 P.Article

DOPPELBLINDSTUDIE MIT NAB 365 UND ZWEI WEITEREN SYMPATHIKOMINETIKA ZUR UEBERPRUEFUNG VON LUNGENFUNKTIONS-UND KREISLAUF PARAMETERN SOWIE DES SCHLAFVERHALTENS = ETUDE A DOUBLE INSU AVEC LE NAB 365 ET DEUX AUTRES SYMPATHOMIMETIQUES DE L'ACTION SUR LA FONCTION PULMONAIRE SUR LES PARAMETRES DE LA CIRCULATION ET SUR LE SOMMEILLOOS M.1975; WIEN. MED. WSCHR.; OESTERR.; DA. 1975; SUPPL. 23; PP. 7-11; BIBL. 16 REF.Article

ANTITUSSIVE THERAPIE CHRONISCH-UNSPEZIFISCHER BRONCHIAL- UND LUNGENKRANKHEITEN. (DOPPLBLINDUSTRIE) = LA THERAPEUTIQUE ANTITUSSIVE DES AFFECTIONS NON SPECIFIQUES CHRONIQUES DES BRONCHES ET DES POUMONS) (ESSAI A DOUBLE INSU)LOOS M.1973; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1973; VOL. 23; NO 2A; PP. 331-336; ABS. ANGL. ESP.; BIBL. 15REF.Serial Issue

KLINISCHE BEFUNDE BEI KINDERN MIT SELEKTIVEM MANGEL AN CLQ, EINER UNTEREINHEIT DER ERSTEN KOMPLENENTKOMPONENTE = SIGNES CLINIQUES CHEZ LES ENFANTS AYANT UN DEFICIT SELECTIF DE LA FRACTION CLQ DU COMPLEMENTBERKEL AI; LOOS M.1983; MONATSSCHRIFT FUER KINDERHEILKUNDE; ISSN 0026-9298; DEU; DA. 1983; VOL. 131; NO 3; PP. 161-165; ABS. ENG; BIBL. 11 REF.Article

KILLING OF THE S AND RE FORMS OF SALMONELLA MINNESOTA VIA THE CLASSICAL PATHWAY OF COMPLEMENT ACTIVATION INGUINEA-PIG AND HUMAN SERACLAS F; LOOS M.1980; IMMUNOLOGY; GBR; DA. 1980; VOL. 40; NO 4; PP. 547-556; BIBL. 19 REF.Article

ANTIBODY-INDEPENDENT BINDING OF THE FIRST COMPONENT OF COMPLEMENT (C1) AND ITS SUBCOMPONENT C1Q TO THE S AND R FORMS OF SALMONELLA MINNESOTACLAS F; LOOS M.1981; INFECT. IMMUN.; ISSN 0019-9567; USA; DA. 1981; VOL. 31; NO 3; PP. 1138-1144; BIBL. 19 REF.Article

TRINITROPHENYLATED RED CELLS (E-TNP) AS A MODEL FOR ANTIBODY-INDEPENDENT ACTIVATION OF THE COMPLEMENT SYSTEM VIA THE CALSSICAL PATHWAY.LOOS M; THESEN R.1978; J. IMMUNOL.; USA; DA. 1978; VOL. 121; NO 1; PP. 24-28; BIBL. 22 REF.Article

Bacteria and complement. A historical reviewLOOS, M.Current Topics in Microbiology and Immunology. 1985, Vol 121, pp 1-5, issn 0070-217XArticle

The complement system: activation and controlLOOS, M.Current Topics in Microbiology and Immunology. 1985, Vol 121, pp 7-18, issn 0070-217XArticle

ANALYSIS OF THE ANTICOMPLEMENTARY ACTIVITY IN SERA OF THREE AFRICAN PATIENTS WITH PARASITIC AND BACTERIOLOGICAL INFECTIONSLOOS M; DIERICH MP.1980; INFECT. AND IMMUN.; USA; DA. 1980; VOL. 27; NO 1; PP. 1-5; BIBL. 9 REF.Article

INTERACTION OF DNP-ANTIGENS WITH THE FIRST COMPONENT OF COMPLEMENT (C1).LOOS M; KONIG W.1977; J. IMMUNOL.; U.S.A.; DA. 1977; VOL. 118; NO 1; PP. 223-225; BIBL. 11 REF.Article

PLANUNG UND AUSWERTUNG DES KONTROLLIERTEN KLINISCHEN VERSUCHS (DEMONSTRIERT AM BEISPIEL CINER WIRKSAMKEITSPRUEFUNG DER KOMBINATION VON PENTOSANPOLYSULFAT UND NICOTINSAEURE BEI ZEREBRALEN DURCHBLUTUNGSSTOERUNGEN) = PLANIFICATION ET EVALUATION DE L'ESSAI CLINIQUE CONTROLE (DEMONTRE SUR L'EXEMPLE D'UN ESSAI D'ACTIVITE DE L'ASSOCIATION DE POLYSULFATE DE PENTOSANE ET D'ACIDE NICOTINIQUE DANS LES PERTURBATIONS DE LA CIRCULATION CEREBRALELOOS M; RAHLFS VW.1976; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1976; VOL. 26; NO 4; PP. 584-591; ABS. ANGL.; BIBL. 16 REF.Article

Le fonctionnement à faible charge des centrales thermiques industrielles. Application du système TDC 3000 à la conduite des chaudières industrielles = Operating the industrial power plant at part load. The TDC 3000 system applied to the control of industrial boilersLOOS, M.Pétrole et techniques. 1987, Num 331, pp 52-56, issn 0152-5425Article

COMPLEMENT COMPONENTS (C1, C2, C3, C4) IN BRONCHIAL SECRETIONS AFTER INTRANASAL INFECTION OF GUINEA PIGS WITH MYCOPLASMA PNEUMONIAE: DISSOCIATION OF UNSPECIFIC AND SPECIFIC DEFENSE MECHANISMSLOOS M; BRUNNER H.1979; INFECT. AND IMMUN.; USA; DA. 1979; VOL. 25; NO 2; PP. 583-585; BIBL. 16 REF.Article

AMYLOID P COMPONENT - A SPECIAL TYPE OF COLLAGENSCHNEIDER HM; LOOS M.1978; VIRCHOWS ARCH., B; DEU; DA. 1978; VOL. 29; NO 3; PP. 225-228; BIBL. 5 REF.Article

Courant mystique et courant hérétique dans la société byzantine in XVI. Internationaler Byzantinistenkongress, Wien 1981LOOS, M.Jahrbuch der Osterreichischen Byzantinistik Wien. 1982, Vol 32, Num 2, pp 237-246Article

MODE OF INTERACTION OF DIFFERENT POLYANIONS WITH THE FIRST (C1, C1) THE SECOND (C2) AND THE FOURTH (C4) COMPONENT OF COMPLEMENT. IV. ACTIVATION OF C1 IN SERUM BY POLYANIONS.LOOS M; BITTER SHERMANN D.1976; IMMUNOLOGY; G.B.; DA. 1976; VOL. 31; NO 6; PP. 931-934; BIBL. 11 REF.Article

INTERACTION OF THE FIRST (C1), THE SECOND (C2) AND THE FOURTH (C4) COMPONENT OF COMPLEMENT WITH DIFFERENT PREPARATIONS OF BACTERIAL LIPOPOLYSACCHARIDES AND WITH LIPID A = INTERACTION DU PREMIER (C1), DU DEUXIEME (C2) ET DU QUATRIEME (C4) COMPOSANTS DU COMPLEMENT AVEC DIFFERENTES PREPARATIONS DE LIPOPOLYOSIDES BACTERIENS ET AVEC LE LIPIDE ALOOS M; BITTER SUERMANN D; DIERICH M et al.1974; J. IMMUNOL.; U.S.A.; DA. 1974; VOL. 112; NO 3; PP. 935-940; BIBL. 14REF.Article

THE RECONSTITUTION OF HUMAN C1, THE FIRST COMPLEMENT COMPONENT: BINDING OF C1R AND C1S TO C1Q INFLUENCES THE C1Q CONFORMATIONGOLAN MD; HITSCHOLD T; LOOS M et al.1981; FEBS LETT.; ISSN 0014-5793; NLD; DA. 1981; VOL. 128; NO 2; PP. 281-285; BIBL. 17 REF.Article

BIOSYNTHESIS OF THE FIRST COMPONENT OF COMPLEMENT BY HUMAN AND GUINEA PIG PERITONEAL MACROPHAGES: EVIDENCE FOR AN INDEPENDENT PRODUCTION OF THE C1 SUBUNITSMULLER W; HANAUSKE ABEL H; LOOS M et al.1978; J. IMMUNOL.; USA; DA. 1978; VOL. 121; NO 4; PP. 1578-1584; BIBL. 49 REF.Article

COMPARISON OF THREE INSTRUMENTAL METHODS TO MONITOR NITROGEN DIOXIDE.KRETZSCHMAR JG; LOOS M; BOSMANS F et al.1977; SCI. TOTAL ENVIRONMENT; NETHERL.; DA. 1977; VOL. 7; NO 2; PP. 181-187; BIBL. 5 REF.Article

PREPARATION OF TRINITROPHENYLATED RED CELLS FOR ANTIBODY INDEPENDENT LYSIS BY COMPLEMENT.THESEN R; BACK W; LOOS M et al.1978; J. IMMUNOL. METHODS; NETHERL.; DA. 1978; VOL. 20; PP. 201-209; BIBL. 18 REF.Article

MODE OF INTERACTION OF DIFFERENT POLYANIONS WITH THE FIRST (C1, C1), THE SECOND (C2) AND THE FOURTH (C4) COMPONENT OF COMPLEMENT. III. INHIBITION OF C4 AND C2 BINDING SITE (S) ON C1S BY POLYANIONS.LOOS M; VOLANAKIS JE; STROUD RM et al.1976; IMMUNOCHEMISTRY; G.B.; DA. 1976; VOL. 13; NO 9; PP. 789-791; BIBL. 12 REF.Article

THE FIRST COMPONENT OF COMPLEMENT IN SERUM. EVIDENCE FOR A HITHERTO UNRECOGNIZED FACTOR IN C1 NECESSARY FOR INTERNAL ACTIVATIONLOOS M; BORSOS T; RAPP HJ et al.1973; J. IMMUNOL.; U.S.A.; DA. 1973; VOL. 110; NO 1; PP. 205-212; BIBL. 22REF.Serial Issue

  • Page / 7